- Home
- WKSP vs CARM Comparison
WKSP vs CARM Comparison
Compare WKSP & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- CARM
- Stock Information
- Founded
- WKSP 2003
- CARM 2016
- Country
- WKSP United States
- CARM United States
- Employees
- WKSP N/A
- CARM N/A
- Industry
- WKSP Auto Parts:O.E.M.
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- WKSP Consumer Discretionary
- CARM Health Care
- Exchange
- WKSP Nasdaq
- CARM Nasdaq
- Market Cap
- WKSP 14.6M
- CARM 16.4M
- IPO Year
- WKSP N/A
- CARM N/A
- Fundamental
- Price
- WKSP $3.06
- CARM $0.28
- Analyst Decision
- WKSP Strong Buy
- CARM Hold
- Analyst Count
- WKSP 3
- CARM 5
- Target Price
- WKSP $12.83
- CARM $0.90
- AVG Volume (30 Days)
- WKSP 331.4K
- CARM 382.4K
- Earning Date
- WKSP 08-13-2025
- CARM 08-22-2025
- Dividend Yield
- WKSP N/A
- CARM N/A
- EPS Growth
- WKSP N/A
- CARM N/A
- EPS
- WKSP N/A
- CARM N/A
- Revenue
- WKSP $12,395,166.00
- CARM $10,767,000.00
- Revenue This Year
- WKSP $151.32
- CARM N/A
- Revenue Next Year
- WKSP $74.19
- CARM N/A
- P/E Ratio
- WKSP N/A
- CARM N/A
- Revenue Growth
- WKSP 232.13
- CARM N/A
- 52 Week Low
- WKSP $2.44
- CARM $0.14
- 52 Week High
- WKSP $12.00
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- WKSP 45.00
- CARM 40.00
- Support Level
- WKSP $3.12
- CARM $0.28
- Resistance Level
- WKSP $3.90
- CARM $0.30
- Average True Range (ATR)
- WKSP 0.31
- CARM 0.02
- MACD
- WKSP -0.03
- CARM -0.00
- Stochastic Oscillator
- WKSP 28.89
- CARM 30.77
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.